Our study analyzed general clinical and laboratory characteristics and found that LY, tumor burden, N classification, radiographic response, pulmonary atelectasis, and pre-treatment PD-L1 expression level were independent factors affecting MPR rate. Here, CD274 is linked to neoplasm.